Laporan Laba Rugi NIPH_R2 - TTM - EI- Nile Co. for Pharmaceuticals and Chemical Industries - Equity Right

Laporan Laba Rugi (TTM)

Laporan Laba Rugi EI- Nile Co. for Pharmaceuticals and Chemical Industries - Equity Right menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	818	785	762	756	744	788	812	877	901	936	983	1,005	1,153	1,272	1,285	1,143	886	972	1,047
Change (%)		-3.99	-2.98	-0.81	-1.47	5.85	3.02	8.02	2.74	3.94	5.00	2.24	14.66	10.32	1.05	-11.08	-22.49	9.74	7.77
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	561	552	552	554	558	587	602	654	675	700	725	733	823	918	953	890	708	744	770
Change (%)		-1.60	-0.06	0.41	0.63	5.16	2.54	8.73	3.22	3.59	3.69	1.07	12.18	11.56	3.84	-6.58	-20.49	5.16	3.46
% of Revenue	68.67	70.38	72.50	73.38	74.95	74.47	74.13	74.61	74.97	74.72	73.78	72.94	71.36	72.16	74.16	77.91	79.92	76.58	73.51

Gross Operating Profit	256	233	209	201	186	201	210	223	226	237	258	272	330	354	332	252	178	228	277
Change (%)		-9.24	-9.91	-4.01	-7.28	7.89	4.40	5.98	1.32	4.98	8.87	5.55	21.34	7.23	-6.20	-23.97	-29.54	27.98	21.87
% of Revenue	31.33	29.62	27.50	26.62	25.05	25.53	25.87	25.39	25.03	25.28	26.22	27.06	28.64	27.84	25.84	22.09	20.08	23.42	26.49

SG&A	92	80	76	83	80	84	87	92	94	97	98	100	103	105	104	102	99	103	109
Change (%)		-12.41	-4.70	8.92	-3.56	4.24	3.47	5.65	2.68	3.56	0.46	2.32	3.42	1.79	-1.61	-1.55	-3.08	4.55	5.03
% of Revenue	11.20	10.22	10.04	11.02	10.79	10.62	10.67	10.44	10.43	10.39	9.94	9.95	8.97	8.28	8.06	8.93	11.16	10.63	10.36

R&D
Change (%)
% of Revenue

OpEx	693	668	661	660	657	689	705	751	771	799	827	842	938	1,036	1,065	999	812	847	882
Change (%)		-3.59	-1.04	-0.13	-0.45	4.87	2.30	6.60	2.63	3.59	3.50	1.90	11.35	10.42	2.83	-6.21	-18.75	4.37	4.08
% of Revenue	84.70	85.06	86.75	87.35	88.25	87.44	86.83	85.69	85.60	85.31	84.09	83.81	81.39	81.46	82.90	87.44	91.66	87.17	84.19

Operating Income	125	117	101	96	87	99	107	125	130	138	156	163	215	236	220	144	74	125	166
Change (%)		-6.21	-13.99	-5.26	-8.52	13.15	8.02	17.35	3.43	6.02	13.73	4.04	31.81	9.90	-6.81	-34.68	-48.53	68.74	32.85
% of Revenue	15.30	14.94	13.25	12.65	11.75	12.56	13.17	14.31	14.40	14.69	15.91	16.19	18.61	18.54	17.10	12.56	8.34	12.83	15.81

Interest Expense	-5	-5	-4	-4	-2	-2	-2	-3	-3	-10	-19	-14	-21	-18	-17	-25	-25	-36	-47
Change (%)		4.01	-26.98	4.32	-34.25	-25.23	17.74	49.71	-13.19	273.47	89.06	-29.52	50.10	-14.95	-1.91	47.33	0.45	40.06	31.21
% of Revenue	-0.57	-0.61	-0.46	-0.49	-0.32	-0.23	-0.26	-0.36	-0.31	-1.10	-1.98	-1.37	-1.79	-1.38	-1.34	-2.22	-2.87	-3.66	-4.46

Net Income	100	98	87	64	61	67	73	90	92	94	99	119	152	169	163	90	25	61	93
Change (%)		-2.58	-11.32	-25.57	-5.55	10.69	8.88	22.28	2.37	2.44	5.21	20.50	27.69	10.91	-3.40	-44.67	-72.68	147.00	51.94
% of Revenue	12.25	12.43	11.36	8.53	8.17	8.55	9.03	10.23	10.19	10.04	10.06	11.86	13.21	13.28	12.69	7.90	2.78	6.26	8.83

Source: Capital IQ

EI- Nile Co. for Pharmaceuticals and Chemical Industries - Equity Right - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)